Clinical Trials on Central Nervous System Tumors

Total 142146 results

Wake Forest University Health Sciences
Emory University

Completed

A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas (Poly-ICLC)

Brain Tumors

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Melphalan With BBBD in Treating Patients With Brain Malignancies

Lymphoma | Brain and Central Nervous System Tumors | Metastatic Cancer

United States
Johns Hopkins All Children's Hospital

Terminated

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Central Nervous System Tumors

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Withdrawn

Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery

Unspecified Adult Solid Tumor, Protocol Specific | Tumors Metastatic to Brain

United States
Emory University
CURE Childhood Cancer, Inc.; Peach Bowl LegACy Fund

Completed

WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors

Brain Tumor | Medulloblastoma | Brain Metastases

United States
Bradmer Pharmaceuticals Inc.

Unknown

Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme

Brain Tumors

United States
Y-mAbs Therapeutics
Memorial Sloan Kettering Cancer Center

Terminated

Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer

Sarcoma | Brain and Central Nervous System Tumors | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Children With Recurrent Solid Tumors

Sarcoma | Brain and Central Nervous System Tumors | Neuroblastoma

United States, Australia, Canada
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Infertility | Brain and Central Nervous System Tumors | Chemotherapeutic Agent Toxicity

United States
University of Manitoba

Completed

Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes

Brain Tumor | Neuroendocrine Cancer

Canada
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma

Malignant Brain Tumor | Brain Stem Glioma,

France
Case Comprehensive Cancer Center

Completed

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Brain and Central Nervous System Tumors | Metastatic Cancer | Radiation Toxicity

United States
Rigshospitalet, Denmark
Karolinska University Hospital; Aarhus University Hospital; Sahlgrenska University... and other collaborators

Not yet recruiting

RE-irradiation of Diffuse MIdline Glioma paTients (REMIT)

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Glioma | Pontine Tumors | Brain Tumor, Pediatric | Thalamic Tumor
Assiut University

Not yet recruiting

Role of Surgery in Management of Pineal Region Tumors in Children

Brain Tumor
Sociedad de Lucha Contra el Cáncer del Ecuador

Not yet recruiting

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Glioma | Neoplasms, Neuroepithelial | Neuroectodermal Tumors | Central Nervous System Neoplasms | Brain Tumor | High Grade Glioma | Glioma, Malignant | Neoplasm Malignant | Photosensitizing Agents | Tumour, Residual | Brain Neoplasms, Adult, Malignant

Ecuador
Mingge LLC
Fudan University; Huashan Hospital

Enrolling by invitation

MRI-based Computer Aided Diagnosis Software (V1) for Glioma

Glioma | Primary Brain Tumor

China
Novartis Pharmaceuticals

Completed

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Lymphoma | Breast Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Melanoma (Skin) | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome

United States
SonoClear AS

Recruiting

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Glioblastoma | High Grade Glioma | Low-grade Glioma | Brain Tumour

Germany, Slovakia, Italy
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); SWOG Cancer Research Network

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer

Brain and Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

Brain and Central Nervous System Tumors

United States
Children's Cancer and Leukaemia Group

Unknown

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery

Brain and Central Nervous System Tumors

United Kingdom, Ireland
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Relapsed Solid Tumor | Refractory Solid Tumor

United States, France, Australia, Belgium, Germany, Japan, Spain, Italy
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); BerGenBio ASA

Terminated

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center

Completed

Sirolimus in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Study of Blood and Cheek Cell Samples From Patients With Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

O(6)-Benzylguanine in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

CCI-779 in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma

Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Terminated

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
European Organisation for Research and Treatment...

Unknown

Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

Brain and Central Nervous System Tumors

United Kingdom
Duke University
National Cancer Institute (NCI)

Completed

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
The Cleveland Clinic

Unknown

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Barrett Cancer Center

Unknown

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma

Brain and Central Nervous System Tumors

United States
Atlantic Health System

Unknown

Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Brain and Central Nervous System Tumors

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma

Brain and Central Nervous System Tumors

United States, Canada
Duke University

Completed

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States

Clinical Trials on Central Nervous System Tumors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations